<div class="container">

<table style="width: 100%;"><tr>
<td>ex0432</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Therapeutic Marijuana</h2>

<h3>Description</h3>

<p>To investigate the capacity of marijuana to reduce the side effects of
cancer chemotherapy, researchers performed a double-blind, randomized,
crossover trial.  Fifteen cancer patients on chemotherapy were
randomly assigned to receive either a marijuana treatment or a placebo
treatment after their first three sessions of chemotherapy.  They were
then crossed over to the opposite treatment for their next 3 sessions.
</p>


<h3>Usage</h3>

<pre><code class="language-R">ex0432</code></pre>


<h3>Format</h3>

<p>A data frame with 15 observations on the following 3 variables.
</p>

<dl>
<dt><code>Subject</code></dt>
<dd>
<p>subject number 1–15</p>
</dd>
<dt><code>Marijuana</code></dt>
<dd>
<p>total number of vomiting and retching
episodes under marijuana treatment</p>
</dd> 
<dt><code>Placebo</code></dt>
<dd>
<p>total number of vomiting and retching episodes
under placebo treatment</p>
</dd> 
</dl>
<h3>Source</h3>

<p>Ramsey, F.L. and Schafer, D.W. (2002). <em>The Statistical Sleuth: A
Course in Methods of Data Analysis (2nd ed)</em>, Duxbury.
</p>


<h3>References</h3>

<p>Chang, A.E., Shiling, D.J., Stillman, R.C., Goldberg, N.H., Seipp,
C.A., Barofsky, I., Simon, R.M. and Rosenberg,
S.A. (1979). Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer
Patients Receiving High Dose Methotrexate, <em>Annals of Internal
Medicine</em> <b>91</b>(6): 819–824.
</p>


<h3>Examples</h3>

<pre><code class="language-R">str(ex0432)
</code></pre>


</div>